These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32710812)

  • 1. Value of Urine Peptides in Assessing Kidney and Cardiovascular Disease.
    Latosinska A; Siwy J; Faguer S; Beige J; Mischak H; Schanstra JP
    Proteomics Clin Appl; 2021 Jan; 15(1):e2000027. PubMed ID: 32710812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of the CKD273 peptide classifier in predicting chronic kidney disease progression.
    Critselis E; Lambers Heerspink H
    Nephrol Dial Transplant; 2016 Feb; 31(2):249-54. PubMed ID: 25791724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary proteomics using capillary electrophoresis coupled to mass spectrometry for diagnosis and prognosis in kidney diseases.
    Magalhães P; Mischak H; Zürbig P
    Curr Opin Nephrol Hypertens; 2016 Nov; 25(6):494-501. PubMed ID: 27584928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Urinary Biomarkers For Improved Prediction Of Progressive Egfr Loss In Early Chronic Kidney Disease Stages And In High Risk Individuals Without Chronic Kidney Disease.
    Rodríguez-Ortiz ME; Pontillo C; Rodríguez M; Zürbig P; Mischak H; Ortiz A
    Sci Rep; 2018 Oct; 8(1):15940. PubMed ID: 30374033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of kidney fibrosis with urinary peptides: a path towards non-invasive liquid biopsies?
    Magalhães P; Pejchinovski M; Markoska K; Banasik M; Klinger M; Švec-Billá D; Rychlík I; Rroji M; Restivo A; Capasso G; Bob F; Schiller A; Ortiz A; Perez-Gomez MV; Cannata P; Sanchez-Niño MD; Naumovic R; Brkovic V; Polenakovic M; Mullen W; Vlahou A; Zürbig P; Pape L; Ferrario F; Denis C; Spasovski G; Mischak H; Schanstra JP
    Sci Rep; 2017 Dec; 7(1):16915. PubMed ID: 29208969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary Peptidomic Biomarkers in Kidney Diseases.
    Sirolli V; Pieroni L; Di Liberato L; Urbani A; Bonomini M
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31877774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of urinary peptidomics in kidney disease research.
    Klein J; Bascands JL; Mischak H; Schanstra JP
    Kidney Int; 2016 Mar; 89(3):539-45. PubMed ID: 26880450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary peptidome analyses for the diagnosis of chronic kidney disease in dogs.
    Pelander L; Brunchault V; Buffin-Meyer B; Klein J; Breuil B; Zürbig P; Magalhães P; Mullen W; Elliott J; Syme H; Schanstra JP; Häggström J; Ljungvall I
    Vet J; 2019 Jul; 249():73-79. PubMed ID: 31239169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CKD273, a new proteomics classifier assessing CKD and its prognosis.
    Argilés Á; Siwy J; Duranton F; Gayrard N; Dakna M; Lundin U; Osaba L; Delles C; Mourad G; Weinberger KM; Mischak H
    PLoS One; 2013; 8(5):e62837. PubMed ID: 23690958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Advances in Urinary Peptide and Proteomic Biomarkers in Chronic Kidney Disease: A Systematic Review.
    Catanese L; Siwy J; Mischak H; Wendt R; Beige J; Rupprecht H
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of metabolomic and proteomic biomarkers in detection and prognosis of progression of renal function in chronic kidney disease.
    Nkuipou-Kenfack E; Duranton F; Gayrard N; Argilés À; Lundin U; Weinberger KM; Dakna M; Delles C; Mullen W; Husi H; Klein J; Koeck T; Zürbig P; Mischak H
    PLoS One; 2014; 9(5):e96955. PubMed ID: 24817014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Renal Denervation on Urinary Peptide-Based Biomarkers in Hypertension.
    Lauder L; Siwy J; Mavrogeorgis E; Keller F; Kunz M; Wachter A; Emrich IE; Böhm M; Mischak H; Mahfoud F
    Hypertension; 2024 Jun; 81(6):1374-1382. PubMed ID: 38572643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary Protein and Peptide Markers in Chronic Kidney Disease.
    Chebotareva N; Vinogradov A; McDonnell V; Zakharova NV; Indeykina MI; Moiseev S; Nikolaev EN; Kononikhin AS
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease.
    Good DM; Zürbig P; Argilés A; Bauer HW; Behrens G; Coon JJ; Dakna M; Decramer S; Delles C; Dominiczak AF; Ehrich JH; Eitner F; Fliser D; Frommberger M; Ganser A; Girolami MA; Golovko I; Gwinner W; Haubitz M; Herget-Rosenthal S; Jankowski J; Jahn H; Jerums G; Julian BA; Kellmann M; Kliem V; Kolch W; Krolewski AS; Luppi M; Massy Z; Melter M; Neusüss C; Novak J; Peter K; Rossing K; Rupprecht H; Schanstra JP; Schiffer E; Stolzenburg JU; Tarnow L; Theodorescu D; Thongboonkerd V; Vanholder R; Weissinger EM; Mischak H; Schmitt-Kopplin P
    Mol Cell Proteomics; 2010 Nov; 9(11):2424-37. PubMed ID: 20616184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary peptidomic biomarkers of renal function in heart transplant recipients.
    Huang QF; Zhang ZY; Van Keer J; Trenson S; Nkuipou-Kenfack E; Yang WY; Thijs L; Vanhaecke J; Van Aelst LNL; Van Cleemput J; Janssens S; Verhamme P; Mischak H; Staessen JA
    Nephrol Dial Transplant; 2019 Aug; 34(8):1336-1343. PubMed ID: 29982668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary peptidomics in kidney disease and drug research.
    Krochmal M; Schanstra JP; Mischak H
    Expert Opin Drug Discov; 2018 Mar; 13(3):259-268. PubMed ID: 29240457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary proteomics based on capillary electrophoresis-coupled mass spectrometry in kidney disease: discovery and validation of biomarkers, and clinical application.
    Mischak H; Delles C; Klein J; Schanstra JP
    Adv Chronic Kidney Dis; 2010 Nov; 17(6):493-506. PubMed ID: 21044772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary peptide-based classifier CKD273: towards clinical application in chronic kidney disease.
    Pontillo C; Mischak H
    Clin Kidney J; 2017 Apr; 10(2):192-201. PubMed ID: 28694965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive diagnosis of chronic kidney diseases using urinary proteome analysis.
    Siwy J; Zürbig P; Argiles A; Beige J; Haubitz M; Jankowski J; Julian BA; Linde PG; Marx D; Mischak H; Mullen W; Novak J; Ortiz A; Persson F; Pontillo C; Rossing P; Rupprecht H; Schanstra JP; Vlahou A; Vanholder R
    Nephrol Dial Transplant; 2017 Dec; 32(12):2079-2089. PubMed ID: 27984204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary proteomics as a novel tool for biomarker discovery in kidney diseases.
    Wu J; Chen YD; Gu W
    J Zhejiang Univ Sci B; 2010 Apr; 11(4):227-37. PubMed ID: 20349519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.